Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: RNA sequencing of 100 individuals of Batrachium bungei

PROVIDER: PRJNA820952 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18512400_1.fastq.gz	Fastqsanger.gz
	SRR18512400_2.fastq.gz	Fastqsanger.gz
	SRR18512401_1.fastq.gz	Fastqsanger.gz
	SRR18512401_2.fastq.gz	Fastqsanger.gz
	SRR18512402_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 200

Similar Datasets

Project description:RNA sequencing of 100 individuals of Batrachium bungei

| PRJNA820952 | ENA

BARIA baseline100

Project description:BARIA baseline first 100 individuals, metagenomes

| PRJEB47902 | ENA

Catalpa bungei

Project description:Catalpa bungei Genome sequencing

| PRJNA780358 | ENA

Diagnostic Exome Sequencing in Persons with Severe Intellectual Disability.

Project description:Intellectual disability is a common condition that carries lifelong severe medical and developmental consequences. The causes of intellectual disability (ID) remain unknown for the majority of patients due to the extensive clinical and genetic heterogeneity of this disorder. De novo mutations may play an important role in ID as most individuals with ID present as isolated cases without family history and/or clear syndromic indication. In addition, the involvement of such mutations have recently been demonstrated in a small number of individuals with ID. Here we evaluate the diagnostic potential and role of de novo mutations in a cohort of 100 patients with ID of unknown cause using family-based exome sequencing. Single end short-read (50 bp) SOLiD 4 sequencing data for 300 individuals, constituting 100 patient-parent trios. For more details please read; http://www.nejm.org/doi/full/10.1056/NEJMoa1206524. Dataset is created by RUNMC (Radboud University, Nijmegen Medical Center), partner of Geuvadis consortium (http://www.geuvadis.org).

2013-11-06 | E-GEUV-5 | biostudies-arrayexpress

Identification of the molecular basis of anti-cancer effect of Huaier.

Project description:Intervention type:DRUG. Intervention1:Huaier, Dose form:GRANULES, Route of administration:ORAL, intended dose regimen:20 to 60/day by either bulk or split for 3 months to extended term if necessary. Control intervention1:None. Primary outcome(s): For mRNA libraries, focus on mRNA studies. Data analysis includes sequencing data processing and basic sequencing data quality control, prediction of new transcripts, differential expression analysis of genes. Gene Ontology (GO) and the KEGG pathway database are used for annotation and enrichment analysis of up-regulated genes and down-regulated genes. For small RNA libraries, data analysis includes sequencing data process and sequencing data process QC, small RNA distribution across the genome, rRNA, tRNA, alignment with snRNA and snoRNA, construction of known miRNA expression pattern, prediction New miRNA and Study of their secondary structure Based on the expression pattern of miRNA, we perform not only GO / KEGG annotation and enrichment, but also different expression analysis.. Timepoint:RNA sequencing of 240 blood samples of 80 cases and its analysis, scheduled from June 30, 2022..

| 2612481 | ecrin-mdr-crc

Catalpa bungei

Project description:Catalpa bungei overview

| PRJNA428098 | ENA

Project description:RNA sequencing of 100 hepatocellular carcinoma

| PRJNA867011 | ENA

Project description:Restriction-site associated DNA (RAD) sequencing of 100 backcross individuals in silkworm

| PRJNA453838 | ENA

Characterization of a macrophage population under the control of nerves in the gastrointestinal tract

Project description:Primary objectives: Characterization of the macrophage population subset that is modulated by enteric neurons Primary endpoints: Characterization of the macrophage population subset that is modulated by enteric neurons via RNA sequencing

| 2538227 | ecrin-mdr-crc

Catalpa bungei

Project description:Catalpa bungei Genome sequencing and assembly

| PRJNA649659 | ENA